# Effects of Black Soy Peptide Supplementation on Blood Pressure

Study · id `cardio:ct-nct01674491` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01674491](<https://clinicaltrials.gov/study/NCT01674491>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01674491

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT01674491. Randomized; quadruple masking; primary purpose basic science. Start 2011-07 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose basic science
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01674491, source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)
- Start date: 2011-07 (registry gives no type) (ClinicalTrials.gov record NCT01674491, source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)
- Primary completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01674491, source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)
- Completion: 2012-03 (actual) (ClinicalTrials.gov record NCT01674491, source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01674491, source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01674491-2012-08-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Black Soy Peptide Supplementation on Blood Pressure
- Condition: Hypertension
- Intervention (Dietary supplement): black soy peptide
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: cf27330549d1e2b0a9b7a2b411f8344117b7f18c0f1369ce6361a8911a97f7ac
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
